• 主页
  • 查找结果
  • miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.

miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.

Molecular cancer (2014-07-20)
Deepti Malik, Deepak Kaul, Nalini Chauhan, Ram Kumar Marwaha
摘要

microRNAs (miRNAs) play both oncogenic and oncostatic roles in leukemia. However, the molecular details underlying miRNA-mediated regulation of their target genes in pediatric B- and T-cell acute lymphoblastic leukemias (ALLs) remain unclear. The present study investigated the relationship between miR-2909 and Kruppel-like factor 4 (KLF4), and its functional relevance to cell cycle progression and immortalization in patients with pediatric ALL. Elevated levels of miR-2909 targeted the tumor suppressor gene KLF4 in pediatric B-cell, but not pediatric T-cell ALL, as detected by pMIR-GFP reporter assay. Expression levels of genes including apoptosis-antagonizing transcription factor (AATF), MYC, B-cell lymphoma (BCL3), P21CIP, CCND1 and SP1 in B- and T-cells from patients with pediatric ALL were compared with control levels using real-time quantitative reverse transcription polymerase chain reaction, western blotting, and reporter assays. We identified two novel mutations in KLF4 in pediatric T-ALL. A mutation in the 3' untranslated region of the KLF4 gene resulted in loss of miR-2909-mediated regulation, while mutation in its first or third zinc-finger motif (Zf1/Zf3) rendered KLF4 transcriptionally inactive. This mutation was a frameshift mutation resulting in alteration of the Zf3 motif sequence in the mutant KLF4 protein in all pediatric T-ALL samples. Homology models, docking studies and promoter activity of its target gene P21CIP confirmed the lack of function of the mutant KLF4 protein in pediatric T-ALL. Moreover, the inability of miR-2909 to regulate KLF4 and its downstream genes controlling cell cycle and apoptosis in T-cell but not in B-ALL was verified by antagomiR-2909 transfection. Comprehensive sequence analysis of KLF4 identified the predominance of isoform 1 (~55 kDa) in most patients with pediatric B-ALL, while those with pediatric T-ALL expressed isoform 2 (~51 kDa). This study identified a novel miR-2909-KLF4 molecular axis able to differentiate between the pathogeneses of pediatric B- and T-cell ALLs, and which may represent a new diagnostic/prognostic marker.

材料
货号
品牌
产品描述

Sigma-Aldrich
ANTI-SP1 antibody produced in mouse, clone 4H6, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-SP1 antibody produced in mouse, clone 2G5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-SP1 antibody produced in mouse, clone 3H7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-SP1 antibody produced in mouse, clone 1G9, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-DAND5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-SP1 antibody produced in mouse, clone 4C8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-SP1 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-SP1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-SP1 (AB1) antibody produced in rabbit, IgG fraction of antiserum
Sigma-Aldrich
Anti-SP1 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
抗 SP1 兔抗, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-SP1 antibody produced in mouse, clone 1A5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
抗 SP1 兔抗, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Sp1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Rabbit anti-Sp1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
Sigma-Aldrich
Goat anti-Sp1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。